Vimta Labs Peer Comparison

NSE: VIMTALABS | BSE: 524394

₹617.70

₹2.70 (0.44%)

As on 28-Aug-2026IST

Market cap

₹2,760 Cr

Revenue (TTM)

₹419 Cr

P/E Ratio

34.6

P/B Ratio

5.9

Div. Yield

0.3 %

Edit

	Vimta Labs	Genesis IBRC India	Jeevan Scientific	Anthem Biosciences	Global Health
Market cap (₹ Cr)	2,760	180	147	50,741	39,538
Revenue (₹ Cr)	419	--	71	2,002	4,683
Net Profit (₹ Cr)	79.66	-0.86	5.14	575.95	552.34
Net Margin (%)	18.53	-2,391.67	7.16	26.66	11.55
RoE (%)	18.52	-3.56	5.85	20.48	14.93
Price to Earnings	34.65	--	42.12	88.10	71.09
Price-To-Book	5.87	4.52	2.01	16.21	9.62

Income Statement (₹ Cr)

	Vimta Labs	Genesis IBRC India	Jeevan Scientific	Anthem Biosciences	Global Health
Operating Revenue	407.29	--	46.84	2,124.33	4,410.27
Total Income	416.28	3.67	47.52	2,280.12	4,514.67
Total Expenditure	265.77	0.16	39.30	1,290.36	3,486.05
EBITDA	141.52	-0.16	7.55	833.97	924.22
Depreciation	43.77	--	6.25	134.07	222.54
EBIT	97.75	-0.16	1.29	699.90	701.68
Interest	1.17	--	1.92	7.06	90.05
Other Income	8.99	3.67	0.68	155.78	104.41
Exceptional Items	-1.62	--	--	-24.39	-1.02
Profit before Tax	103.95	3.50	0.05	824.24	715.02
Provision for Tax	26.44	--	-0.01	232.45	160.95
Profit after Tax	77.51	3.50	0.06	591.79	554.07

	Vimta Labs	Genesis IBRC India	Jeevan Scientific	Anthem Biosciences	Global Health
Shareholder's Funds	456.87	8.53	49.94	3,042.52	3,961.57
Minority Interest	--	--	0.13	--	22.71
Non-Current Liabilities	33.55	--	15.23	33.74	1,277.95
Current Liabilities	65.52	0.30	12.07	529.71	627.13
Total Liabilities	562.23	8.84	78.29	3,633.29	5,905.00

	Vimta Labs	Genesis IBRC India	Jeevan Scientific	Anthem Biosciences	Global Health
Non-Current Assets	331.07	--	48.61	1,598.82	4,214.44
Current Assets	224.87	8.84	28.76	2,007.15	1,674.92
Total Assets	562.23	8.84	78.29	3,633.29	5,905.00
Total Debt*	3.33	0.00	15.14	51.07	631.08
Net Current Assets	159.35	8.53	16.69	1,477.43	1,047.79
Contingent Liabilities	1.95	--	--	90.20	100.01

	Vimta Labs	Genesis IBRC India	Jeevan Scientific	Anthem Biosciences	Global Health
Cash From Operating Activities	147.14	0.00	10.07	844.49	714.39
Cash Flow from Investing Activities	-129.67	--	-15.62	-701.62	-1,089.11
Cash from Financing Activities	-10.35	--	5.24	-40.00	271.85
Net Cash Inflow / Outflow	7.12	0.00	-0.30	102.87	-102.87

	Vimta Labs	Genesis IBRC India	Jeevan Scientific	Anthem Biosciences	Global Health
ROCE (%)	24.81	51.69	3.17	29.62	19.38
ROE (%)	18.87	51.69	0.14	21.98	15.12
ROA (%)	15.25	49.91	0.08	18.06	10.43
EBIT Margin (%)	36.95	--	17.55	46.59	23.32
Net Margin (%)	18.62	95.57	0.12	25.95	12.27
Cash Profit Margin (%)	29.78	--	13.47	33.25	17.61

	Vimta Labs	Genesis IBRC India	Jeevan Scientific	Anthem Biosciences	Global Health
Revenue Growth (%)	18.40	--	18.14	15.17	19.44
EBIT Growth (%)	19.27	192.30	53.88	30.79	6.57
Net Profit Growth (%)	16.11	192.29	104.45	31.14	15.11
EPS Growth (%)	15.59	192.29	109.10	30.53	15.54
Book Value Growth (%)	20.79	69.71	1.09	26.67	16.51

	Vimta Labs	Genesis IBRC India	Jeevan Scientific	Anthem Biosciences	Global Health
Price / Earnings	21.95	6.80	526.25	62.29	46.44
Price / Book Value	3.78	2.79	1.45	12.25	6.55
Dividend Yield (%)	0.53	0.00	0.00	0.30	0.05
EV/EBITDA	10.89	6.80	9.54	37.02	24.64
Market Cap (₹ Cr)	1,701.05	--	63.50	36,865.25	25,841.07

	Vimta Labs	Genesis IBRC India	Jeevan Scientific	Anthem Biosciences	Global Health
Debt to Equity	0.01	0.00	0.34	0.02	0.16
Short term debt to equity ratio	--	--	0.02	0.00	--
Current Ratio	3.43	29.18	2.38	3.79	2.67
Quick Ratio	2.97	29.18	2.25	3.55	2.54
Interest Coverage	90.08	--	1.03	117.83	8.94

	Vimta Labs	Genesis IBRC India	Jeevan Scientific	Anthem Biosciences	Global Health
Debtors to sales (%)	25.95	--	34.03	27.80	9.32
Asset Turnover	0.80	0.00	0.65	0.67	0.83
Receivable days	94.97	--	110.00	87.02	29.09
Inventory Days	24.65	--	10.55	38.87	6.05
Payable days	--	--	255.53	41.63	80.04
Cash Conversion Cycle	--	--	-134.98	84.26	-44.90

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.